Metraipolis › archive › dc_fd21bcbaf424

Clinical and genomic determinants associated with emergent ceftazidime-avibactam plus aztreonam non-susceptibility in ceftazidime-avibactam resistant… — Europe PMC PMID:41870042

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41870042
DOI
10.1128/aac.01860-25
License (as archived)
solo-consultazione
Archived
2026-11-04T02:11:28.966Z
SHA-256 of the archived text
a88dff1fe0661fff6ca01898c82b38230f5905f57d37eb89e8006414f957cdd6
Stable URL of this page
https://metraipolis.com/documento/dc_fd21bcbaf424

How to cite

Clinical and genomic determinants associated with emergent ceftazidime-avibactam plus aztreonam non-susceptibility in ceftazidime-avibactam resistant… — Europe PMC PMID:41870042 — Europe PMC (en), https://europepmc.org/article/MED/41870042 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fd21bcbaf424 (Metraipolis archive dc_fd21bcbaf424, sha256 a88dff1fe0661fff6ca01898c82b38230f5905f57d37eb89e8006414f957cdd6)
BibTeX
@misc{dcfd21bcbaf424,
  title = {Clinical and genomic determinants associated with emergent ceftazidime-avibactam plus aztreonam non-susceptibility in ceftazidime-avibactam resistant… — Europe PMC PMID:41870042},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41870042},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fd21bcbaf424; sha256 a88dff1fe0661fff6ca01898c82b38230f5905f57d37eb89e8006414f957cdd6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41870042. Agents can read the archived copy with the MCP tool read_document.